Capital International, Inc. Abbott Laboratories Transaction History

Capital International, Inc.

$7.57 Billion
Q3 2024

A detailed history of Capital International, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Capital International, Inc. holds 600,787 shares of ABT stock, worth $68.7 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

600,787

Previous 570,093 5.38%

Holding current value

$68.7 Million

Previous $59.2 Million 15.63%

% of portfolio

0.9%

Previous 0.82%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $3.07 Million - $3.63 Million	30,694 Added 5.38%	600,787 $68.5 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $8.12 Million - $9.07 Million	80,653 Added 16.48%	570,093 $59.2 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $10 Million - $11.1 Million	91,640 Added 23.04%	489,440 $55.6 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $6.62 Million - $8.1 Million	73,404 Added 22.63%	397,800 $43.8 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $1.75 Million - $2.09 Million	-18,272 Reduced 5.33%	324,396 $31.4 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $3.78 Million - $4.21 Million	37,516 Added 12.29%	342,668 $37.4 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $57,437 - $67,607	593 Added 0.19%	305,152 $30.9 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.07 Million - $1.25 Million	11,228 Added 3.83%	304,559 $33.4 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $18.5 Million - $21.5 Million	-191,669 Reduced 39.52%	293,331 $28.4 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $411,648 - $497,551	-4,033 Reduced 0.82%	485,000 $52.7 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $3.65 Million - $4.45 Million	-32,009 Reduced 6.14%	489,033 $57.9 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $145,452 - $178,098	-1,259 Reduced 0.24%	521,042 $73.3 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $6.12 Million - $6.77 Million	-52,493 Reduced 9.13%	522,301 $61.7 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $1.17 Million - $1.38 Million	-11,095 Reduced 1.89%	574,794 $66.6 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $3.24 Million - $3.81 Million	-29,740 Reduced 4.83%	585,889 $70.2 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $195,300 - $212,821	1,860 Added 0.3%	615,629 $67.4 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $325,230 - $394,968	-3,549 Reduced 0.57%	613,769 $66.8 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $3.41 Million - $4.36 Million	44,489 Added 7.77%	617,318 $56.4 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $2.22 Million - $3.24 Million	35,277 Added 6.56%	572,829 $45.2 Million
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $277,846 - $309,308	3,539 Added 0.66%	537,552 $46.7 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $40.1 Million - $43.5 Million	489,742 Added 1106.24%	534,013 $44.7 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $2.05 Million - $2.39 Million	28,175 Added 175.04%	44,271 $3.72 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $112,574 - $136,102	-1,700 Reduced 9.55%	16,096 $1.29 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $119,778 - $135,691	-1,827 Reduced 9.31%	17,796 $1.29 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $427,068 - $515,207	7,023 Added 55.74%	19,623 $1.44 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $28,785 - $31,770	-500 Reduced 3.82%	12,600 $768,000
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $737,137 - $833,422	13,100 New	13,100 $785,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Abbott Laboratories Transaction History